ストックスクリーナーアプリを入手
7.68
0.39%
0.03
アフターアワーズ：
7.68
Xencor Inc (XNCR) 最新ニュース
Is it time to cut losses on Xencor Inc.Gold Moves & AI Forecast for Swing Trade Picks - Newser
Advanced analytics toolkit walkthrough for Xencor Inc.Market Performance Recap & Growth Focused Stock Pick Reports - Newser
Using fundamentals and technicals on Xencor Inc.Market Performance Recap & Breakout Confirmation Alerts - Newser
What earnings revisions data tells us about Xencor Inc.2025 Market WrapUp & Accurate Trade Setup Notifications - Newser
Using data tools to time your Xencor Inc. exitRisk Management & Technical Pattern Alert System - Newser
Heatmap analysis for Xencor Inc. and competitorsJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser
Regression analysis insights on Xencor Inc. performanceJuly 2025 WrapUp & Fast Gain Swing Alerts - Newser
How Xencor Inc. stock performs during market volatilityWeekly Profit Recap & AI Driven Price Predictions - Newser
Xencor Inc. stock trend outlook and recovery pathQuarterly Profit Review & Short-Term High Return Ideas - Newser
What’s the analyst consensus on Xencor Inc.July 2025 Opening Moves & Capital Efficient Trading Techniques - thegnnews.com
Will Xencor Inc. Sustain Its Chart Breakout2025 Price Action Summary & Long-Term Capital Growth Strategies - metal.it
Xencor’s SWOT analysis: biotech stock faces pivotal clinical trials - Investing.com
Wedbush Estimates Xencor’s Q3 Earnings (NASDAQ:XNCR) - Defense World
William Blair Analysts Boost Earnings Estimates for Xencor - Defense World
Using portfolio simulators with Xencor Inc. includedEntry Confirmation Using Short-Term Forecasting - Newser
Wedbush Cuts Xencor (NASDAQ:XNCR) Price Target to $26.00 - Defense World
Xencor, Inc. (NASDAQ:XNCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - uk.finance.yahoo.com
Xencor price target lowered to $26 from $31 at Wedbush - Yahoo Finance
Xencor’s XmAb541 Study Completion: A Potential Game-Changer in Oncology - TipRanks
Xencor’s XmAb808 Study: A New Frontier in Cancer Treatment - TipRanks
Xencor’s XmAb541 Study: A Promising Step in Cancer Treatment - TipRanks
Xencor’s XmAb942 Shows Promising Efficacy and Strategic Advancements, Earning a Buy Rating - TipRanks
Wedbush Cuts Price Target on Xencor to $26 From $31, Keeps Outperform Rating - MarketScreener
Xencor’s Strategic Advances and Promising Pipeline Drive Buy Rating - TipRanks
Xencor 2025 Q2 Earnings Strong Revenue Growth, 55.2% Reduction in Net Loss - AInvest
Xencor Inc earnings beat by $0.31, revenue topped estimates - Investing.com India
Xencor Reports Second Quarter 2025 Financial Results - BioSpace
Xencor, Inc. Reports Revenue Growth Amidst Continued Losses - TipRanks
Xencor: Q2 Earnings Snapshot - San Antonio Express-News
Xencor Q2 Earnings: Losses Reported but Revenue Surpasses ExpectationsNews and Statistics - IndexBox
Xencor (XNCR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Xencor (XNCR) Q2 Revenue Jumps 82% - sharewise.com
Xencor, Inc.'s (NASDAQ:XNCR) Price Is Right But Growth Is Lacking - simplywall.st
Published on: 2025-08-06 00:25:22 - Newser
What’s the recovery path for long term holders of Xencor Inc.Free Pattern Detection for Entry Confirmation - Newser
Xencor Inc. Flashes Rebound Signal in Oversold ConditionConfirmed Setup With Expert Accuracy Supported - metal.it
How does Xencor Inc. generate profit in a changing economyRapid market gains - Jammu Links News
What is the dividend policy of Xencor Inc. stockMaximize portfolio value with expert tips - Jammu Links News
When is Xencor Inc. stock expected to show significant growthSuperior capital gains - Jammu Links News
What is Xencor Inc. company’s growth strategyLightning-fast growth - Jammu Links News
Is it the right time to buy Xencor Inc. stockSky-high return potential - Jammu Links News
How many analysts rate Xencor Inc. as a “Buy”Overwhelming profit margins - Jammu Links News
What catalysts could drive Xencor Inc. stock higher in 2025Strong return on investment - Jammu Links News
How does Xencor Inc. compare to its industry peersConsistent triple returns - Jammu Links News
Should I hold or sell Xencor Inc. stock in 2025Triple-digit growth rates - Jammu Links News
Is Xencor Inc. a growth stock or a value stockFree Expert Stock Watchlist - Jammu Links News
Is Xencor Inc. a good long term investmentCapitalize on market momentum for big wins - Jammu Links News
Xencor Appoints Raymond Deshaies to Board of Directors to Bolster Drug Development Efforts - AInvest
How volatile is Xencor Inc. stock compared to the marketJaw-dropping returns - Jammu Links News
Xencor (XNCR) Expected to Announce Quarterly Earnings on Monday - Defense World
Xencor XNCR 2025Q2 Earnings Preview Upside Potential on Robust Revenue Growth - AInvest
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):